http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013201688-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1548dbd2d994c74461d3db005c06fe39 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate | 2013-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f12e4b71307b8bec1ff603991c7c3a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdc0859bc00d55c7d409168fce8b2fd9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b1bf1603bd24fa60c1ac9991f01d195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c69d25b8a30164f8c9215b782f0a6321 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2fce27a2b70ec7b6992cc33c764682b |
publicationDate | 2016-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2013201688-B2 |
titleOfInvention | Antagonists of PCSK9 |
abstract | ANTAGONISTS OF PCSK9 Antagonists of human proprotein convertase subtilisin-kexin type 9 ("PCSK9") are disclosed. The disclosed antagonists are effective in the inhibition of PCSK9 function and, accordingly, present desirable antagonists for the use in the treatment of conditions associated with PCSK9 activity. The present invention also discloses nucleic acid encoding said antagonists, vectors, host cells, and compositions comprising the antagonists. Methods of making PCSK9-specific antagonists as well as methods of using the antagonists for inhibiting or antagonizing PCSK9 function are also disclosed and form important additional aspects of the present disclosure. |
priorityDate | 2006-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 120.